Chief, Hematology Oncology

The Yale Cancer Center (YCC) and the Department of Internal Medicine at the Yale School of Medicine (YSM) seek a nationally recognized, dynamic, and visionary leader to become the Section Chief of Medical Oncology and Hematology in the Department of Internal Medicine and the Deputy Director for Clinical Affairs at the YCC. As the leader of one of the largest and most complex sections within the Department of Medicine, the Section Chief of Medical Oncology and Hematology is responsible for academic advancement, mentorship, and career development of the faculty. As the Deputy Director for Clinical Affairs at the YCC, they will support and engage clinicians across multiple specialties and multiple sites. These critical roles bridge clinical excellence, research innovation, and faculty development at one of the nation’s most storied academic medical centers and is a transformative opportunity to lead at a premier institution where world-class science meets a rapidly expanding clinical enterprise. 

For more than 50 years, the Yale Cancer Center has been Connecticut’s only NCI-designated Comprehensive Cancer Center and one of only three in New England. It notably brings together both inpatient and outpatient care in one hospital on the main campus while also having 14 other care delivery locations in the states of Connecticut and Rhode Island. All of these sites are staffed exclusively by Yale faculty in the section of Medical Oncology and Hematology. The YCC leverages the resources of both the school and the hospital to advance research, prevention, and patient care. The center’s mission is to conduct research, develop therapies, and provide patient care by integrating the expertise of physicians, nurses, and scientists from both the school and the hospital.

Cancer research at Yale began decades before the YCC was founded, when the first use of chemotherapy, nitrogen mustard, was administered at Yale New Haven Hospital (YNHH) in 1942. Since that first use of chemotherapy, research efforts have expanded to include three Specialized Program of Research Excellence (SPORE) grants in lung cancer, head and neck cancer, and skin cancer, and about 100 NCI-funded research projects. With the development of a CAR T-Cell Therapy Program, and a Phase I Program that offers over 40 phase I trials to patients, YCC has become a world leader in cancer care, research, and education, delivering transformative scientific discoveries and care innovations to patients.

The Section of Medical Oncology and Hematology oversees close to 130 faculty members, including clinical faculty, clinical trialists, physician-scientists, and research scientists located at multiple sites across the Yale New Haven Health System, and a thriving Medical Oncology-Hematology fellowship program recruiting ten fellows each year. Members of the Section deliver cancer care and treat nearly 48% of the state’s cancer patients, offering 13 disease-specific centers of excellence statewide. This statewide system provides the opportunity to pioneer innovative approaches across diverse communities and in a variety of different clinical settings. The faculty have a broad range of expertise in carrying out bench-to-bedside research, leading clinical trials, providing care to patients and survivors impacted by all cancer types, and educating the next generation of physicians and researchers.

The Section Chief of Medical Oncology and Hematology partners closely with clinical and operational leaders across YSM, YCC, and Smilow Cancer Hospital. Reporting to the Director of the YCC and the Chair of Internal Medicine, the Section Chief will be a respected physician and successful researcher who has a deep commitment to the tripartite mission, inclusive of optimizing clinical care; supporting discovery, translational, clinical, and health services research; mentoring faculty and fellows; and guiding administrative, budgetary, and philanthropic efforts. This position offers an opportunity to strengthen the alignment of the academic mission with clinical growth in a growing statewide health system. The Section Chief will be a transparent, collaborative, and creative leader who will be a champion for innovation, have an inclusive leadership mindset, and have a passion for engaging multidisciplinary teams in a matrixed environment. This leader will exemplify and encourage a culture of inclusivity, mentorship, and professional development; have a team-based approach; and recruit highly qualified faculty, staff, and trainees. 

An MD, DO, or MD/PhD, with board certification in medical oncology and/or hematology, is required. The successful candidate will have a record commensurate with appointment at the rank of full professor in the Department of Internal Medicine and the School of Medicine. 

Please direct all inquiries, nominations, and applications below. All replies will be held in strict confidence. Correspondence and applications, which should include a CV and letter of interest, should be submitted electronically below. 

Ariannah Mirick is leading this search with Jane McInerney and Madeleine Ruth.

The final candidate, upon acceptance of a contingent offer of employment/faculty appointment, may be required to disclose whether they are, or have been, the subject of any disciplinary proceeding (investigation, hearing, etc.) at previous institutions or employers, and may also be subject to a background screening. Candidates who materially misrepresent information on their resume or other application materials are ineligible for hire/appointment. Final candidates may also be required to sign a release to allow Yale to solicit information regarding any substantiated conduct violations from current and/or past employers.

Yale is an equal opportunity employer: https://your.yale.edu/policies-procedures/policies/9000-yale-university-policy-against-discrimination-and-harassment#9000.1 Yale values diversity among its students, staff, and faculty and welcomes applications from candidates with a broad range of backgrounds and perspectives. Title IX of the Education Amendments of 1972 protects people from sex discrimination in educational programs and activities at institutions that receive federal financial assistance. Questions regarding Title IX may be referred to the University’s Title IX Coordinator, at TitleIX@yale.edu, or to the U.S. Department of Education, Office for Civil Rights, 8th Floor, Five Post Office Square, Boston MA 02109-3921. Telephone: 617.289.0111, Fax: 617.289.0150, TDD: 800.877.8339, or Email: ocr.boston@ed.gov.